Cancer Immunotherapy Research

Cancer immunotherapy has become an extremely promising approach for the treatment of cancer. Immune checkpoint blockade, adoptive cell transfer, and altering the tumor microenvironment are three approaches to cancer immunotherapy that are being actively investigated. More research in all of these areas is needed to gain a better understanding of responses to cancer immunotherapy and to direct more effective therapeutic strategies moving forward. The Bio-Techne life science brands—R&D Systems, Tocris Bioscience, Novus Biologicals, and ProteinSimple—offer an extensive selection of reagents, kits, small molecules, assay platforms, and custom services that can facilitate your research and assist in driving this important field forward.